Wistuba II - Search Results

1

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.

Levy BP, Chioda MD, Herndon D, Longshore JW, Mohamed M, Ou SH, Reynolds C, Singh J, Wistuba II, Bunn PA Jr, Hirsch FR. Levy BP, et al. Among authors: wistuba ii. Oncologist. 2015 Oct;20(10):1175-81. doi: 10.1634/theoncologist.2015-0114. Epub 2015 Sep 1. Oncologist. 2015. PMID: 26330460 Free PMC article.

2

Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations.

Field JK, Brambilla C, Caporaso N, Flahault A, Henschke C, Herman J, Hirsch F, Lachmann P, Lam S, Maier S, Montuenga LM, Mulshine J, Murphy M, Pullen J, Spitz M, Tockman M, Tyndale R, Wistuba I, Youngson J. Field JK, et al. Int J Oncol. 2002 Aug;21(2):369-73. doi: 10.3892/ijo.21.2.369. Int J Oncol. 2002. PMID: 12118333 Review.

3

Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma.

Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson BE, Hirsch F, Brambilla E, Flieder DB, Geisinger KR, Thunnisen F, Kerr K, Yankelevitz D, Franks TJ, Galvin JR, Henderson DW, Nicholson AG, Hasleton PS, Roggli V, Tsao MS, Cappuzzo F, Vazquez M. Travis WD, et al. Among authors: wistuba ii. J Clin Oncol. 2005 May 10;23(14):3279-87. doi: 10.1200/JCO.2005.15.776. J Clin Oncol. 2005. PMID: 15886315 Review.

4

Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer.

Gu J, Berman D, Lu C, Wistuba II, Roth JA, Frazier M, Spitz MR, Wu X. Gu J, et al. Among authors: wistuba ii. Clin Cancer Res. 2006 Dec 15;12(24):7329-38. doi: 10.1158/1078-0432.CCR-06-0894. Clin Cancer Res. 2006. PMID: 17189404

5

Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.

Tsao AS, Tang XM, Sabloff B, Xiao L, Shigematsu H, Roth J, Spitz M, Hong WK, Gazdar A, Wistuba I. Tsao AS, et al. J Thorac Oncol. 2006 Mar;1(3):231-9. doi: 10.1016/s1556-0864(15)31573-2. J Thorac Oncol. 2006. PMID: 17409862 Free article.

6

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.

Massarelli E, Varella-Garcia M, Tang X, Xavier AC, Ozburn NC, Liu DD, Bekele BN, Herbst RS, Wistuba II. Massarelli E, et al. Among authors: wistuba ii. Clin Cancer Res. 2007 May 15;13(10):2890-6. doi: 10.1158/1078-0432.CCR-06-3043. Clin Cancer Res. 2007. PMID: 17504988

7

Molecular pathogenesis of early-stage non-small cell lung cancer and a proposal for tissue banking to facilitate identification of new biomarkers.

Raso MG, Wistuba II. Raso MG, et al. Among authors: wistuba ii. J Thorac Oncol. 2007 Jul;2(7 Suppl 3):S128-35. doi: 10.1097/JTO.0b013e318074fe42. J Thorac Oncol. 2007. PMID: 17603309 Free article.

8

Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer.

Seo HS, Liu DD, Bekele BN, Kim MK, Pisters K, Lippman SM, Wistuba II, Koo JS. Seo HS, et al. Among authors: wistuba ii. Cancer Res. 2008 Aug 1;68(15):6065-73. doi: 10.1158/0008-5472.CAN-07-5376. Cancer Res. 2008. PMID: 18676828 Free PMC article.

9

Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cells.

Zhang J, Iwanaga K, Choi KC, Wislez M, Raso MG, Wei W, Wistuba II, Kurie JM. Zhang J, et al. Among authors: wistuba ii. Cancer Prev Res (Phila). 2008 Aug;1(3):201-7. doi: 10.1158/1940-6207.CAPR-08-0014. Epub 2008 Mar 31. Cancer Prev Res (Phila). 2008. PMID: 19138957 Free PMC article.

10

Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer.

Brannan JM, Dong W, Prudkin L, Behrens C, Lotan R, Bekele BN, Wistuba I, Johnson FM. Brannan JM, et al. Clin Cancer Res. 2009 Jul 1;15(13):4423-30. doi: 10.1158/1078-0432.CCR-09-0473. Epub 2009 Jun 16. Clin Cancer Res. 2009. PMID: 19531623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

730 results

Search Page

Filters